Is Corbus Pharmaceuticals Holdings Inc halal to invest in?

As of July 2026, Corbus Pharmaceuticals Holdings Inc 3371.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Corbus Pharmaceuticals Holdings Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Corbus Pharmaceuticals Holdings Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Corbus Pharmaceuticals Holdings Inc?

Muslim investors may consider investing in Corbus Pharmaceuticals Holdings Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Corbus Pharmaceuticals Holdings Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Corbus Pharmaceuticals Holdings Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Corbus Pharmaceuticals Holdings Inc updated?

The Shariah compliance status of Corbus Pharmaceuticals Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Corbus Pharmaceuticals Holdings Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Corbus Pharmaceuticals Holdings Inc?

You can check the latest Shariah compliance status of Corbus Pharmaceuticals Holdings Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Corbus Pharmaceuticals Holdings Inc 3371.SG

Last Updated: Mar 13, 12:00 AM·XSTU

3371.SG Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Corbus Pharmaceuticals Holdings Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Corbus Pharmaceuticals Holdings Inc. Stock Analysis 3371.SG

Germany Health Care Micro Cap Report: Q1, 2026

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. The company is headquartered in Norwood, Massachusetts and currently employs 36 full-time employees. The company went IPO on 2014-10-24. The firm has a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The Company’s oncology pipeline comprises two experimental drugs targeting solid tumors: CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFB expressed on cancer cells. CRB-701 is a monoclonal antibody attached to a monomethyl auristatin E (MMAE) cytotoxic payload using a proprietary linker technology. The pipeline also includes CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. CB1 inverse agonism is a clinically validated mechanism to induce weight loss.

Key Statistics of Corbus Pharmaceuticals Holdings Inc (3371.SG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€6.30€6.30

Today's Open

€6.30

Volume

P/E Ratio (TTM)

Financial Metrics & Statements of Corbus Pharmaceuticals Holdings Inc (3371.SG)

Super Investors Invested in Corbus Pharmaceuticals Holdings Inc (3371.SG)

FAQ's for Corbus Pharmaceuticals Holdings Inc (3371.SG)

As of July 2026, Corbus Pharmaceuticals Holdings Inc 3371.SG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Corbus Pharmaceuticals Holdings Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Corbus Pharmaceuticals Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Corbus Pharmaceuticals Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Corbus Pharmaceuticals Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Corbus Pharmaceuticals Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.